The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Infections as a major preventable cause of human cancer
Open accessAbstract
Abstract. Kuper H, Adami H‐O & Trichopoulos D (Harvard School of Public Health, Boston, MA, USA; Karolinska Institute, Stockholm, Sweden; University of Athens Medical School, Greece). Infections as a major preventable cause of human cancer (Internal Medicine in the 21st Century). J Intern Med 2000; 248: 171–183. Infections may be responsible for over 15% of all malignancies worldwide. Important mechanisms by which infectious agents may induce carcinogenesis include the production of chronic inflammation, the transformation of cells by insertion of oncogenes and inhibition of tumour suppressors, and the induction of immunosuppression. Common characteristics shared by infectious agents linked to malignancies are that they are persistent in the host, often highly prevalent in the host population and induce cancer after a long latency. The associations between a selection of infectious agents and malignancies are covered in detail.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many cancers arise from sites of infection, chronic irritation and inflammation.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Tumour cells produce various cytokines and chemokines that attract leukocytes.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“The Gram-negative bacterium H. pylori is established as a definite carcinogen for the development of gastric cancer — the second most common type of cancer globally11,29 — and DNA damage resulting from chronic inflammation is believed the mechanism32.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Genetic and functional experiments indicate that neutrophils, mast cells, eosinophils and activated T lymphocytes also contribute to malignancies by releasing extracellular proteases, pro-angiogenic factors and chemokines11,23–26.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,766
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C., Hwang, L., & Chien, C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,856
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.bloodjournal503481 · Cited by 2,315
Helicobacter pylori Infection and Gastric Lymphoma
Parsonnet, J., Hansen, S., Rodríguez, L. V., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich∥, N., Vogelman∥, J. H., & FRIEDMAN, G. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301803 · Cited by 1,826
Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,297
Münger, K., Werness, B. A., Dyson, N. J., Phelps, W. C., Harlow, E. E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 1,204
An international association between Helicobacter pylori infection and gastric cancer
The EUROGAST Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)90938-d · Cited by 1,158
Moore, P. S., & Chang, Y. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321801 · Cited by 1,095
IARC monographs on the evaluation of carcinogenic risks to humans
International Agency for Research on Cancer (1996) · Analytica Chimica Acta · doi:10.1016/s0003-2670(97)89591-8 · Cited by 1,091
Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B. M., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6 · Cited by 1,082
Ohshima, H., & Bartsch, H. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90245-3 · Cited by 1,050
Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?
Beral, V., Peterman, T. A., Berkelman, R. L., & Jaffe, H. W. (1990) · The Lancet · doi:10.1016/0140-6736(90)90001-l · Cited by 1,046
Global surveillance and control of hepatitis C
(1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.6120139.x · Cited by 903
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 841
Huerta, G. T., & Villasana, J. E. M. (1988) · PubMed · Cited by 804
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
Gao, S., Kingsley, L., Li, M. O., Zheng, W., Parravicini, C., Ziegler, J. L., Newton, R., Rinaldo, C. R., Saah, A. J., Phair, J., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-925 · Cited by 793
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
Sexual Transmission and the Natural History of Human Herpesvirus 8 Infection
Martin, J. N., Ganem, D. E., Osmond, D. H., Page, K. A., Macrae, D., & Kedes, D. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381403 · Cited by 712
Oore, P. A. S. M., & Hang, Y. (1995) · Cited by 667
Epidemiology of Hodgkin's Disease
MacMahon, B. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92483-5 · Cited by 483
Jones, D. L., Alani, R. M., & Münger, K. (1997) · Genes & Development · doi:10.1101/gad.11.16.2101 · Cited by 476
The Pathogenesis of Burkitt's Lymphoma
MAGRATH, I. T. (1990) · Advances in cancer research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 467
Hodgkin's Disease and Epstein-Barr Virus
Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich∥, N., Polk, B. F., & Vogelman∥, J. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201103 · Cited by 445
The influence of age on the development of the hepatitis B carrier state
Edmunds, W. J., Medley, G. F., Nokes, D. J., Hall, A. J., & Whittle, H. (1993) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1993.0102 · Cited by 425
Harwood, C. A., Surentheran, T., McGregor, J., Spink, P. J., Leigh, I. M., Breuer, J., & Proby, C. M. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200007)61:3 · Cited by 420
Ray, R., Lagging, M., Meyer, K., & Ray, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4438-4443.1996 · Cited by 403
Blaser, M. J., Chyou, P.-H., & Nomura, A. M. Y. (1995) · PubMed · Cited by 398
Cancer and infection: estimates of the attributable fraction in 1990.
Pisani, P., Parkin, D. M., Muñóz, N., & Ferlay, J. (1997) · PubMed · Cited by 390
Global programme for control of hepatitis B infection
Kane, M. (1995) · Vaccine · doi:10.1016/0264-410x(95)80050-n · Cited by 384
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Butel, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.405 · Cited by 368
Hepatitis C Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Patients with Cirrhosis
Simonetti, R. G., Cammà, C., Fiorello, F., Cottone, M., Rapicetta, M., Marino, L., Fiorentino, G., Craxı̀, A., Ciccaglione, A. R., Giuseppetti, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-97 · Cited by 352
Shiratori, Y. (1995) · Hepatology · doi:10.1016/0270-9139(95)90605-3 · Cited by 347
Hepatitis B virus and hepatocellular carcinoma
Arbuthnot, P. B., & Kew, M. C. (2001) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2001.iep178.x · Cited by 342
HCV-associated liver cancer without cirrhosis
Mitri, M. S. D., Pisi, E., Poussin, K., Paterlini-Bréchot, P., Bréchot, C., Baccarini, P., D’Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 292
Hepatitis B Virus X Protein Interferes with Cellular DNA Repair
Becker, S. A., Lee, T.-H., Butel, J. S., & Slagle, B. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.266-272.1998 · Cited by 276
Shiratori, Y., Shiina, S., Imamura, M., et al. (1995) · Hepatology · doi:10.1002/hep.1840220403 · Cited by 266
Suppression of Apoptotic Cell Death by Hepatitis C Virus Core Protein
Ray, R. B., Meyer, K., & Ray, R. (1996) · Virology · doi:10.1006/viro.1996.0644 · Cited by 265
Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
Ray, R. B., Lagging, M., Meyer, K., Steele, R., & Ray, R. (1995) · Virus Research · doi:10.1016/0168-1702(95)00034-n · Cited by 253
The control of schistosomiasis. Second report of the WHO expert committee
Sturrock, R. F. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90322-h · Cited by 248
Inhibition of p53 DNA binding by human papillomavirus E6 proteins
Lechner, M. S., & Laimins, L. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4262-4273.1994 · Cited by 238
Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929 · Cited by 237
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor
Matsumoto, M., Hsieh, T., Zhu, N., VanArsdale, T. L., Hwang, S. B., Jeng, K.-S., Gorbalenya, A. E., Lo, S., Ou, J.-H. J., Ware, C. F., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1301-1309.1997 · Cited by 217
Antinore, M. J., Birrer, M. J., Patel, D., Nader, L., & McCance, D. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00546.x · Cited by 210
Ensoli, B. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00037-3 · Cited by 202
Hepatitis B and C Viruses and Their Interaction in the Origin of Hepatocellular Carcinoma
Kaklamani, E. (1991) · JAMA · doi:10.1001/jama.1991.03460150078027 · Cited by 198
Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma
Dm, P., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'Abbé, K. A., & Wild, C. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480302 · Cited by 191
Interassay Correlation of Human Herpesvirus 8 Serologic Tests
Rabkin, C. S., Schulz, T. F., Whitby, D., Lennette, E. T., Magpantay, L. I., Chatlynne, L. G., & Biggar, R. J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515649 · Cited by 189
Atherton, J. C. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011662 · Cited by 188
Epidemiology of Human T-Cell Leukemia/Lymphoma Virus
Blattner, W. A., Blayney, D. W., Robert-Guroff, M., Samgadharan, M. G., Kalyanaraman, V. S., Sarin, P. S., Jaffe, E. S., & Gallo, R. C. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.3.406 · Cited by 179
H. pylori, the most common bacterial infection in Africa: a random serological study.
Holcombe, C., Omotara, B. A., Eldridge, J., & Jones, D. M. (1992) · PubMed · Cited by 177
JEWERS, R. J., Hildebrandt, P., Ludlow, J. W., Kell, B., & McCance, D. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1329-1335.1992 · Cited by 174
久保田, 由., 今山, 修., 三原, 公., 安元, 慎., 村上義之, 堀, 嘉., & Tatsuya, U. Z. A. (1992) · The Nishinihon Journal of Dermatology · Cited by 173
Global programme for control of hepatitis B infection
Kane, M. (1995) · Vaccine · doi:10.1016/0264-410x(95)93547-m · Cited by 165
Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint
Thomas, J. T., & Laimins, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1131-1137.1998 · Cited by 161
Stuver, S. O., Taehibana, N., Okayama, A., Shioiri, S., Tsunetoshi, Y., Tsuda, K., & Mueller, N. E. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.1.57 · Cited by 159
Francis, D. A., Schmid, S. I., & Howley, P. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2679-2686.2000 · Cited by 156
Haswell, M., Satarug, S., Tsuda, M., Mairiang, E., Esumi, H., Sithithaworn, P., Mairiang, P., Saitoh, M., Yongvanit, P., & Elkins, D. B. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90244-5 · Cited by 140
Quasispecies in viral persistence and pathogenesis of hepatitis C virus
Forns, X., Purcell, R. H., & Bukh, J. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01590-5 · Cited by 139
How is Helicobacter pylori Transmitted?
Cave, D. R. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)80004-2 · Cited by 137
Hepatitis b Viruses and Hepatocellular Carcinoma
Buendia, M. A. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60306-1 · Cited by 137
Rosin, M. P., Zaki, S. S. A., Ward, A. J., & Anwar, W. A. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90248-8 · Cited by 132
Overview of the Epidemiology of Immunodeficiency-Associated Cancers
Beral, V., & Newton, R. (1998) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024164 · Cited by 131
Scheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D., & Howley, P. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.5100-5105.1992 · Cited by 129
Epidemiology of Hodgkin's disease
Cole, P. (1972) · JAMA · doi:10.1001/jama.222.13.1636 · Cited by 128
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
Wang, W. L., London, W. T., & Feitelson, M. A. (1991) · PubMed · Cited by 125
The epidemiology of HTLV-I infection
Mueller, N. E. (1991) · Cancer Causes & Control · doi:10.1007/bf00052359 · Cited by 120
Evans, A. S., & Gutensohn, N. M. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340203 · Cited by 118
Balsano, C., Avantaggiati, M. L., Natoli, G., Marzio, E. D., Will, H., Perricaudet, M., & Levrero, M. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90379-l · Cited by 118
Trichopoulos, D., Τζώνου, Α., Kaklamani, E., Zavitsanos, X., Koumantaki, Y., Day, N., Muñóz, N., & Trichopoulou, A. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390109 · Cited by 114
Self-citationDistinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma
Rowe, M., Rooney, C. M., Rickinson, A. B., Lenoir, G., Rupani, H., Moss, D. J., Stein, H., & Epstein, M. A. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350404 · Cited by 110
Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929-1938.1994 · Cited by 104
Hepatitis C Virus and Hepatocellular Carcinoma
Colombo, M. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007116 · Cited by 102
Viruses and cancer causal associations
Evans, A. S., & Mueller, N. E. (1990) · Annals of Epidemiology · doi:10.1016/1047-2797(90)90020-s · Cited by 101
Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis.
Cohen, S. M., Purtilo, D. T., & Ellwein, L. B. (1991) · PubMed · Cited by 95
Risk Factors for Adult T-Cell Leukemia Among Carriers of Human T-Lymphotropic Virus Type I
Hisada, M., Okayama, A., Shioiri, S., Spiegelman, D. L., Stuver, S. O., & Mueller, N. E. (1998) · Blood · doi:10.1182/blood.v92.10.3557 · Cited by 89
Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA.
Hino, O., Tabata, S., & Hotta, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9248 · Cited by 88
Musk, A. W., de Klerk, N. H., Ambrosini, G. L., Eccles, J. L., Hansen, J., Olsen, N. J., Watts, V. L., Lund, H., Pang, S., Beilby, J. P., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3 · Cited by 77
[Epidemiology of Hodgkin's disease].
István, L., & Giczy, S. (1979) · PubMed · Cited by 70
Kuper, H., Τζώνου, Α., Kaklamani, E., Hadziyannis, S. J., Tasopoulos, N., Λάγιου, Π., Trichopoulos, D., & Stuver, S. O. (2000) · Cancer Causes & Control · doi:10.1023/a:1008951901148 · Cited by 69
Self-citationThamavit, W., Pairojkul, C., Tiwawech, D., Ito, M., Shirai, T., & Ito, N. (1993) · Carcinogenesis · doi:10.1093/carcin/14.11.2415 · Cited by 69
Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
Gerbitz, A., Mautner, J., Geltinger, C., Hörtnagel, K., Christoph, B., Asenbauer, H., Klobeck, G., Polack, A., & Bornkamm, G. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202468 · Cited by 60
Newton, R. C. (2000) · Annals of Oncology · doi:10.1023/a:1008381703687 · Cited by 56
Morozov, A., Shiyanov, P. A., Barr, E., Leiden, J. M., & Raychaudhuri, P. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3451-3457.1997 · Cited by 54
Zacny, V. L., Wilson, J., & Pagano, J. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8043-8051.1998 · Cited by 54
The decline in the incidence of stomach cancer in sweden 1960‐1984: A birth cohort phenomenon
Hansson, L., Bergström, R., Sparjén, P., & Adami, H. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470405 · Cited by 49
Self-citationRisk Factors for Adult T-Cell Leukemia Among Carriers of Human T-Lymphotropic Virus Type I
Hisada, M., Okayama, A., Shioiri, S., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3557.422k09_3557_3561 · Cited by 46
Lanier, A. P., Henle, W., Bender, T. R., Henle, G., & Talbot, M. L. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260203 · Cited by 42
Chirivi, R. G. S., Chiodoni, C., Musiani, P., Garofalo, A., Bernasconi, S., Colombo, M. P., & Giavazzi, R. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960917)67:6 · Cited by 40
Epidemiology of Hodgkin's disease
Rothman, H., & Freed, N. (1989) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1989-890612 · Cited by 32
Badawi, A. F., & Mostafa, M. H. (1993) · Journal of International Medical Research · doi:10.1177/030006059302100601 · Cited by 25
Molecular Biology of Human T-Cell Leukemia Virus Associated with Adult T-Cell Leukemia
Yoshida, M., Hattori, S., & Seiki, M. (1985) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-70113-9_11 · Cited by 23
Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma
Chan, C. K., Mueller, N. E., Evans, A. S., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich∥, N., Polk, B. F., & Vogelman∥, J. H. (1991) · Cancer Causes & Control · doi:10.1007/bf00053132 · Cited by 23
The Epstein-Barr Virus and Malignancy: Molecular EvidencePreprint
Pagano, J. S. (1974) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1974.039.01.092 · Cited by 22
Human immunodeficiency virus infection and cancer
Newton, R., Beral, V., & Weiss, R. A. (1998) · Cancer surveys · Cited by 22
Hepatitis Viruses: Their Role in Human Cancer
Bradley, D. W. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.t01-1-99240.x · Cited by 21
Mythily, D. V., Krishna, S., & Tergaonkar, V. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-7-1707 · Cited by 18
Genetic heterogeneity and properties of hepatitis C virus.
Pawlotsky, J. (1998) · PubMed · Cited by 14
Retroviruses—Human Immunodeficiency Virus
Blattner, W. A., OʼBrien, T. R., & Mueller, N. E. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0036-4_24 · Cited by 13
Saito, K., Sullivan, D. E., Haruna, Y., Nd, T., Sn, T., & Gerber, M. A. (1997) · PubMed · Cited by 13
Ultrastructural characteristics of liver fluke associated human cholangiocarcinoma cell lines.
Sriurairatana, S., Tengchaisri, T., & Sirisinha, S. (1996) · PubMed · Cited by 11
Genomic Aberrations of Human Papillomavirus Recovered from Cervical Cancers
Pao, C. C., Yao, D.-S., Lin, C.-Y., Lee, S. C., Su, H. T., & Lin, S. C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0707 · Cited by 7
Ultrastructure of hepatocyte abnormalities in perimetastatic areas.
Me, C., Hj, F., Márquez, A., Arias-Sosa, L. A., & Nl, D. (1998) · PubMed · Cited by 5
Becker, Y., & Hadar, J. (1983) · Springer eBooks · doi:10.1007/978-1-4613-3906-9_10 · Cited by 4
Factors related to the occurrence of gastric adenocarcinoma subtypes
Ekström, A. M. (2000) · Figshare · Cited by 2
Research works printed but not linked: 12
- Parsonnet J., 1999, Microbes and Malignancy., 3
- Zur Hausen H., 1999, Microbes and Malignancy., 107
- IARC, Hepatitis viruses., 1994, IARC monographs on the evaluation of carcinogenic risks to humans.
- Robinson WS., 1999, Microbes and Malignancy., 232
- Chung RT, 1999, Microbes and Malignancy., 267
- IARC, Infections with Epstein–Barr virus, human herpes viruses., 1997, IARC monographs on the evaluation of carcinogenic risks to humans., 70
- Pagona JS., 1975, Cold Spring Harbor Symposium on quantitative biology: tumor viruses, XXIX, 797
- Chang Y., 1999, Microbes and Malignancy., 207
- Newton R, 1999, Infections and Human Cancer., 237
- IARC. Schistosomes, Liver Flukes and Helicobacter Pylori., 1994, Monographs on the Evaluation of Carcinogenic Risks to Humans no. 61.
- Danesh J., 1999, Infections and Human Cancer., 263
- EkströmA‐M.Factors related to the occurence of gastrric adenocarcinoma subtypes.Doctoral Dissertation Stockholm: Karolinska Institutet 2000.
Cited by
Sorted by citations
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,414
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Metadata
- Authors
- Kuper, H., Adami, H. ‐., & Trichopoulos, D.
- Affiliations
- Harvard University (US)
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2000-09
- Volume
- 248
- Issue
- 3
- Pages
- 171-183
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2159454395
- Cited by
- 740
- References
- 109
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 23 · 2023: 44 · 2022: 29 · 2021: 39 · 2020: 36 · 2019: 42 · 2018: 32 · 2017: 41 · 2016: 35 · 2015: 37 · 2014: 32 · 2013: 44 · 2012: 30
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- infection, cancer prevention, carcinogenesis, chronic inflammation, oncogenes, tumour suppressor, immunosuppression, persistent infection, tumor latency
- MeSH terms
- Animals, Clonorchiasis, Humans, Neoplasms, Primary Prevention, Schistosomiasis, Virus Diseases, Helicobacter pylori, Helicobacter Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
